Romano; Joseph J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Romano; Joseph J..The latest application filed is for "heterocyclic amides useful as protein modulators and methods of using the same".
- Romano; Joseph J. - Collegeville PA
- Romano; Joseph J. - Frederick PA
- Romano; Joseph J. - Berwyn PA
- Romano; Joseph J. - Rome IT
| Patent | Date |
|---|---|
| Modulators of stimulator of interferon genes (STING) Grant 11,377,440 - Fosbenner , et al. July 5, 2 | 2022-07-05 |
| Heterocyclic amides useful as protein modulators Grant 11,365,190 - Charnley , et al. June 21, 2 | 2022-06-21 |
| Heterocyclic Amides Useful As Protein Modulators And Methods Of Using The Same App 20210238172 - CHARNLEY; Adam Kenneth ; et al. | 2021-08-05 |
| Heterocyclic Amides Useful As Protein Modulators App 20210139473 - CHARNLEY; Adam Kenneth ; et al. | 2021-05-13 |
| Heterocyclic amides useful as protein modulators Grant 10,981,901 - Romano , et al. April 20, 2 | 2021-04-20 |
| Modulators Of Stimulator Of Interferon Genes (sting) App 20200291001 - FOSBENNER; David T. ; et al. | 2020-09-17 |
| Amino-quinolines as kinase inhibitors Grant 10,220,030 - Bury , et al. | 2019-03-05 |
| Heterocyclic amides useful as protein modulators Grant 10,189,820 - Mehlmann , et al. Ja | 2019-01-29 |
| Amino quinazolines as kinase inhibitors Grant 9,994,529 - Bury , et al. June 12, 2 | 2018-06-12 |
| Heterocyclic Amides Useful As Protein Modulators App 20180105514 - MEHLMANN; John F. ; et al. | 2018-04-19 |
| Amino-quinolines As Kinase Inhibitors App 20180085365 - BURY; Michael Jonathan ; et al. | 2018-03-29 |
| HCV NS3 protease inhibitors Grant 9,738,661 - Liverton , et al. August 22, 2 | 2017-08-22 |
| Amino Quinazolines As Kinase Inhibitors App 20170152233 - BURY; Michael Jonathan ; et al. | 2017-06-01 |
| Amino-quinolines As Kinase Inhibitors App 20170128437 - BURY; Michael Jonathan ; et al. | 2017-05-11 |
| Amino quinazolines as kinase inhibitors Grant 9,604,938 - Bury , et al. March 28, 2 | 2017-03-28 |
| Amino-quinolines as kinase inhibitors Grant 9,604,963 - Bury , et al. March 28, 2 | 2017-03-28 |
| Quinolyl Amines As Kinase Inhibitors App 20160060249 - CASILLAS; Linda N. ; et al. | 2016-03-03 |
| Amino-quinolines As Kinase Inhibitors App 20160060222 - BURY; Michael Jonathan ; et al. | 2016-03-03 |
| HCV NS3 Protease Inhibitors App 20150266897 - Liverton; Nigel J. ; et al. | 2015-09-24 |
| Macrocyclic compounds as antiviral agents Grant 8,927,569 - Harper , et al. January 6, 2 | 2015-01-06 |
| Quinolyl Amines As Kinase Inhibitors App 20140256949 - CASILLAS; Linda N. ; et al. | 2014-09-11 |
| Amino Quinazolines As Kinase Inhibitors App 20140206688 - Bury; Michael Jonathan ; et al. | 2014-07-24 |
| Amino-quinolines As Kinase Inhibitors App 20130345258 - Bury; Michael Jonathan ; et al. | 2013-12-26 |
| Amino-quinolines As Kinase Inhibitors App 20130053375 - Bury; Michael Jonathan ; et al. | 2013-02-28 |
| Imidazolyl-imidazoles As Kinase Inhibitors App 20130018039 - Bodmer; Vera Q. ; et al. | 2013-01-17 |
| HCV NS3 protease inhibitors Grant 8,309,540 - Liverton , et al. November 13, 2 | 2012-11-13 |
| HCV NS3 Protease Inhibitors App 20100286185 - Liverton; Nigel J ; et al. | 2010-11-11 |
| Macrocyclic Compounds As Antiviral Agents App 20100183551 - Harper; Steven ; et al. | 2010-07-22 |
| HCV NS3 Protease Inhibitors App 20100099695 - Liverton; Nigel J. ; et al. | 2010-04-22 |
| Hcv Ns3 Protease Inhibitors App 20100093779 - Liverton; Nigel J. ; et al. | 2010-04-15 |
| N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists Grant 7,259,157 - Liverton , et al. August 21, 2 | 2007-08-21 |
| N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists App 20030119811 - Liverton, Nigel J. ; et al. | 2003-06-26 |
| SEC | 0001182586 | ROMANO JOSEPH J |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 